Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite
- 1 February 1999
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (1-2) , 1135-1137
- https://doi.org/10.1016/s0041-1345(98)01936-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Monoethylglycinexylidide (Megx) Liver Function Test Is Not Compromised by 3–Hydroxy Megx in HumansHepatology, 1998
- Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.Journal of the American Society of Nephrology, 1998
- Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedureClinical Chemistry, 1998
- Therapeutic Drug Monitoring of Mycophenolic Acid: Comparison of HPLC and Immunoassay Reveals New MPA MetabolitesTransplantation Proceedings, 1998
- Successful mycophenolate mofetil treatment of glomerular diseaseAmerican Journal of Kidney Diseases, 1998
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- Mycophenolate MofetilPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1997
- Mycophenolate mofetil: A unique immunosuppressive agentAmerican Journal of Health-System Pharmacy, 1997